
201 - 500 employees
Founded 1998
🏥 Healthcare
💼 Consulting
📦 Logistics
💰 $4.1M Post-IPO Equity - Zealand Pharma on 2025-06
Healthcare • Consulting • Logistics
Zealand Pharma is an international biotechnology company headquartered in Denmark with operations in Boston, USA. It discovers, designs, and develops peptide-based and small-molecule therapeutics focused on transforming metabolic health — particularly obesity — and addressing rare diseases such as congenital hyperinsulinism and short bowel syndrome, as well as chronic inflammatory conditions. Zealand maintains a clinical-stage pipeline of peptide analogs and receptor agonists (e. g. , amylin analogs, GLP/GIP agonists, glucagon analogs) and partners with larger pharma companies to advance programs.
Selected: 🆕 Date Added.
🕒 July 24
Director, HEOR & RWE leading health economics and outcomes research strategies for Zealand Pharma. Generating real-world evidence and collaborating with stakeholders to demonstrate product value.
🏖️ New Jersey, Pennsylvania – Remote
💵 $210k - $250k / year
💰 $4.1M Post-IPO Equity - Zealand Pharma on 2025-06
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 6%